PharmStar Pharmaceuticals Update
August 29 2013 - 7:16PM
The following statement is from Howard Phykitt, President/CEO of
PharmStar Pharmaceuticals, Inc. (Pink Sheets:PHAR):
August 22, 2013
Board of Directors PharmStar Pharmaceuticals, Inc.
Re: Resignation
To Whom It May Concern:
I hereby resign from the position of President, Chief Executive
Officer, and Director of PharmStar Pharmaceuticals, Inc. effective
immediately.
Upon resignation I will retire 405,000,000 shares of PharmStar
Pharmaceuticals, Inc. common stock back to treasury. As
compensation for returning the stock, the board of directors has
unanimously agreed to release all intellectual property rights,
patents and trademarks for soluble aspirin back to Howard Phykitt
personally.
Sincerely,
Howard Phykitt
CONTACT: PharmStar Pharmaceuticals, Inc.
OTC Capital Partners
561-350-8523
www.otccapitalpartners.com